Frost & Sullivan

Virtual Think Tank

It’s Time to Catalyze the Next Step in
Gene Therapy Manufacturing

Future Opportunities Require Innovation, Change, and
New Approaches to Effectively Address Forthcoming Demand

Daniel Ruppar

Daniel Ruppar
Consulting Director,
Healthcare & Life Sciences
Frost & Sullivan

Thursday, June 8, 2023
11:00 AM – 12:00PM EDT

We are pleased to invite you to an exclusive discussion with your peers to gain your perspective in support of our ongoing industry research.

Join us for this Timely Discussion!

Gene therapies and other new therapeutic modalities provide a bright future for the treatment and/or cure of genetic conditions and rare diseases and are a predicted area of robust industry growth. However, these modalities create a range of potential manufacturing challenges to the industry, including the development of scalable, robust, and platformable processes, impacting speed to market and effective capacity for future commercial demands.

The key questions we will be discussing are:

What are the top unmet needs today in gene therapy manufacturing as we move into its next market phase?

How should manufacturers/CDMOs think about balancing risk vs reward when developing new processes?

What are acceptable trade-offs when it comes to throughput, yield, and purity?

What are acceptable trade-offs across serotypes and vectors with respect to platformability and robustness of the process?

How should manufacturers address variance - asset-specific challenges or system requirements of different modalities?

During this Virtual Think Tank, Frost & Sullivan’s Daniel Ruppar, Consulting Director, Healthcare & Life Sciences, will moderate a discussion on what gene therapy manufacturing could look like to best address future opportunity and outcomes.


Alexei Voloshin

Alexei Voloshin
Global Head of
Application Strategy &
Bioprocess Science

Andrew David Tustian

Andrew David Tustian
Senior Director 
Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc
Susan D'Costa

Susan D’Costa
Chief Technology Officer
Alcyone Therapeutics

Alcyone Therapeutics</p>
Daniel Hurwit

Daniel Hurwit
Principal Scientist,
Gene Delivery Process and
Analytical Development
Bristol Myers Squibb

Bristol Myers Squibb
Nripen Singh

Nripen Singh
Head of Process and
Product Development
Passage Bio

Passage Bio
Michael P Mercaldi

Michael P Mercaldi
Vice President, Strategy
and Program Management
Oxford Biomedica Solutions

Oxford Biomedica Solutions
Francesca Vitelli

Francesca Vitelli
Process Development
Intellia Therapeutics, Inc

Intellia Therapeutics


What is a Virtual Think Tank?
A Frost & Sullivan Virtual Think Tank is an exclusive, unique and highly engaging conversation that brings together a diverse group of industry leaders to discuss their opinions on a certain topic. Content from this collective discussion will be featured in an upcoming Frost & Sullivan article where you have the options to be highlighted as a thought leader. Your insight as a strategic partner is invaluable.
Why Should I Participate?
  • Share & Learn Best Practices: Engage in strategic conversations with your peers. The open, candid discussions you have will spark creative thinking and help you formulate new ideas for implementation.
  • Increase Your Peer-to-Peer Network: Connect with other senior level leaders in your industry on a more intimate level.
  • Get Access to a Frost & Sullivan Analyst: Engage with our industry experts to gain additional insights and ask them your questions.
  • Demonstrate Your Industry Expertise: The insights, feedback and best practices shared by you will be part of an upcoming Frost & Sullivan vBook. Through your participation, both you and your company will be positioned as a leader.
Will I have the Option to be Quoted or Not?

Yes, all participants have the options to be quoted or not in the vBook.

Will I get a Copy of this vBook when Published?

Yes, we would be more than happy to send you over a complimentary copy of the vBook once published.

Who can I Speak About Additional Questions?

Please contact Danielle Floyd at

Confirm Your Participation

In Collaboration With

In collaboration with 3M